Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma

BACKGROUND: The World Health Organization (WHO) recommends annual mass azithromycin distribution until districts drop below 5% prevalence of trachomatous inflammation—follicular (TF). Districts with very low TF prevalence may have little or no transmission of the ocular strains of Chlamydia trachoma...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Ophthalmol
Päätekijät: Amza, Abdou, Kadri, Boubacar, Nassirou, Beido, Arzika, Ahmed M., Austin, Ariana, Nyatigo, Fanice, Lebas, Elodie, Arnold, Benjamin F., Lietman, Thomas M., Oldenburg, Catherine E.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2021
Aiheet:
Study Protocol
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7789605/
https://ncbi.nlm.nih.gov/pubmed/33407263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-020-01776-4
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia